Of these randomised patients , @ were treated in the combination phase ( @ in the olaparib plus chemotherapy group and @ in the chemotherapy alone group ) and @ continued to the maintenance or no further treatment phase ( @ in the olaparib plus chemotherapy group and @ in the chemotherapy alone group ) .